Clinical practice guidelines identify the benefits of IV iron preparations as a treatment option for patients with IDA who lack a response to, are non-compliant with, or are intolerant of oral iron treatment, as well as those who have severe iron deficiency and require rapid replenishment of available iron and Hb levels. Here, GSTM1 is linked to Iron deficiency anemia.